Cryosurgery is now being used to treat formations of Morton’s Neuroma, or when a neuroma has formed between the third and fourth toes. The procedure is minimally invasive and has been clinically proven to be a very effective form of treatment of Morton’s Neuroma. The procedure currently has a very high rate of success in Morton’s Neuroma patients as it has not shown a very large degree of complications stemming from the surgery. This procedure also does not present any risk to patients in forming what is known as stump neuroma.
The procedure utilizes a medical-grade nitrous oxide in order to formulate near freezing cold temperatures that will selectively and effectively destroy the nueroma tissue found in between patients’ third and fourth toes. The treatment makes use of a tool known as a cryoprobe that has a six to eight millimeter sort of ice sphere located on its tip. The cryoprobe can reach below freezing temperatures as low as -67 degrees Celsius. By using the cryoprobe, a surgeon is able to destroy the damaged or defective nerve tissue by creating highly extensive vascular damages to the nerve. This damage will cause the nerve to undergo what is known as demyelinazation, the breaking down of myelin sheath and ultimate degeneration of the toe joint’s axon.
Because a cryosurgery injection does not damage the epineurium and perinerium of the nerve it is affecting, there is virtually no chance that the foot will form a stump neuroma. Cryosurgery technology has seen a rather large jump in its usage over the past decade. The success rates of the surgeries have been astounding, currently standing between 85 and 97 percent.
A vast majority of individuals that have gone through cryosurgery injections experienced pain relief immediately after the procedure. If the patient did not receive immediate pain relief, then he or she at least saw significant improvement of their symptoms. The cryoprobe will destroy up to one centimeter of the damaged or defective nerve. The nerve that receives the treatment will usually regenerate at a rate of one to three millimeters per day, on average, so complete regeneration of the nerve may take a few weeks.
There are hardly any recorded complications resulting from cryosurgery. Morton’s Neuroma patients that have received cryosurgery have been able to gain full motor function in their metatarsals and full sensation with great rates of success. There have been some incidents in which patients that have undergone cryosurgery have experienced some pain returning in the area, similar to the symptoms of the treated Morton’s Neuroma, one or two years after the procedure, but this has been a very small percentage of patients. The FDA, the branch that regulates food, drug, and medical processes and procedures, has approved cryosurgery and its usage has become rather widespread.
Patients with poor circulation in their legs and feet may not be candidates for the cryosurgery procedure, for the procedure makes use of extremely cold temperatures. However, for other patients reporting symptoms of Morton’s Neuroma, the cryosurgery procedure is highly recommended by podiatrists.
No responses yet